Guggenheim Reiterates Buy Rating for Cigna Group with $318 PT.
ByAinvest
Monday, Feb 2, 2026 11:29 pm ET1min read
CI--
Guggenheim reiterates its Buy rating for Cigna Group (CI) with a $318 price target. The analyst has maintained its rating and price target since February 2023, showcasing confidence in the company's valuation and performance expectations. Historical ratings demonstrate consistent analyst engagement with rating adjustments over recent months. Cigna Group primarily provides pharmacy benefit management and health insurance services, with a strong position in the US market and a recent multiyear deal with Centene. Analysts forecast an average target price of $327.37 with an upside of 19.14% from the current price of $274.78.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet